表紙
市場調查報告書

轉染試劑、設備的全球市場:2020年∼2024年

Transfection Reagents and Equipment Market by Product and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 918563
出版日期 內容資訊 英文 148 Pages
訂單完成後即時交付
價格
轉染試劑、設備的全球市場:2020年∼2024年 Transfection Reagents and Equipment Market by Product and Geography - Forecast and Analysis 2020-2024
出版日期: 2019年11月26日內容資訊: 英文 148 Pages
簡介

全球轉染試劑、設備市場上,高癌症的得病率和發生率,新興經濟國的醫療基礎設施的改善,及時的疾病診斷需求高漲等成為成長促進因素,在預測期間內預計將以6%以上的年複合成長率擴大。但,DNA及RNA的提取伴隨的風險,基因改造生物輸送的嚴格合規性,及供應商間的激烈競爭等要素,可能妨礙在預測期間內的轉染試劑、設備產業的成長。

本報告提供全球轉染試劑、設備市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2019年)
  • 市場規模及預測(2019年∼2024年)
  • 市場預測

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各產品

  • 市場區隔:各產品
  • 各產品比較:市場規模及預測(2019年∼2024年)
  • 試劑
  • 設備
  • 市場機會:各產品

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2019年∼2024年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 發展中國家的臨床試驗的增加
  • 地緣政治學的不確定性
  • 醫療費的增加

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭方案

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Lonza Group Ltd.
  • MaxCyte Inc.
  • Merck KGaA
  • Polyplus-transfection SA
  • Promega Corp.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR40213

About this market

Technavio's transfection reagents and equipment market analysis considers sales from both reagents and equipment products. Our study also finds the sales of transfection reagents and equipment in Asia, Europe, North America, and ROW. In 2019, the reagents segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increasing commercial adoption and low prices of transfection reagents will play a significant role in the reagents segment to maintain its market position. Also, our global transfection reagents and equipment market report looks at factors such as high prevalence and incidence of cancer, improvement in healthcare infrastructure in emerging economies, and rising demand for timely disease diagnosis. However, the risk associated with the extraction of DNA and RNA, strict compliance regarding the transportation of genetically modified organisms, and intense competition among vendors may hamper the growth of the transfection reagents and equipment industry over the forecast period.

Overview

Rising demand for timely disease diagnosis

Early diagnosis diseases are necessary among patients with a high risk of hereditary conditions. It requires genetic tools to facilitate diagnostic tests such as next-generation sequencing and DNA microarrays. This is driving the demand for transfection reagents as they are used for conducting genetic variation testing procedures. They help in identifying risks of developing diseases such as Alzheimer's disease, Parkinson's disease, and cancer. Thus, the rising demand for timely disease diagnosis will lead to the expansion of the global transfection reagents and equipment market at a CAGR of over 6% during the forecast period.

Rise in clinical trials in developing nations

Transfection reagents are being increasingly used in preclinical studies as well as clinical trials to support the development of novel therapies based on the delivery of nucleic acids. Pharmaceutical companies conduct clinical trials to comply with stringent regulations and reduce their drug development costs. The rise in the number of clinical trials in developing countries can be attributed to factors such as access to a large patient pool, friendly market reforms, strong intellectual property and clinical trial infrastructure, and availability of skilled workforce. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global transfection reagents and equipment market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of several major players, the global transfection reagents and equipment market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transfection reagents and equipment manufacturers, that include Agilent Technologies Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Lonza Group Ltd., MaxCyte Inc., Merck KGaA, Polyplus-transfection SA, Promega Corp., QIAGEN NV, and Thermo Fisher Scientific Inc.

Also, the transfection reagents and equipment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Reagents - Market size and forecast 2019-2024
  • Equipment - Market size and forecast 2019-2024
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Rise in clinical trials in developing nations
  • Geopolitical uncertainties
  • Rising healthcare expenditures

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Lonza Group Ltd.
  • MaxCyte Inc.
  • Merck KGaA
  • Polyplus-transfection SA
  • Promega Corp.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Global healthcare equipment market
  • Exhibit 02: Segments of global healthcare equipment market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Vendor key offerings
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Product - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Reagents - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Reagents - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Equipment - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Equipment - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2019-2024 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Top 3 countries in North America
  • Exhibit 31: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 33: Top 3 countries in Europe
  • Exhibit 34: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: Top 3 countries in Asia
  • Exhibit 37: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 38: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 39: Top 3 countries in ROW
  • Exhibit 40: Key leading countries
  • Exhibit 41: Market opportunity
  • Exhibit 42: Impact of drivers and challenges
  • Exhibit 43: Vendor landscape
  • Exhibit 44: Landscape disruption
  • Exhibit 45: Vendors covered
  • Exhibit 46: Vendor classification
  • Exhibit 47: Market positioning of vendors
  • Exhibit 48: Agilent Technologies Inc. - Vendor overview
  • Exhibit 49: Agilent Technologies Inc. - Business segments
  • Exhibit 50: Agilent Technologies Inc. - Organizational developments
  • Exhibit 51: Agilent Technologies Inc. - Geographic focus
  • Exhibit 52: Agilent Technologies Inc. - Segment focus
  • Exhibit 53: Agilent Technologies Inc. - Key offerings
  • Exhibit 54: Agilent Technologies Inc. - Key customers
  • Exhibit 55: Bio-Rad Laboratories Inc. - Vendor overview
  • Exhibit 56: Bio-Rad Laboratories Inc. - Product segments
  • Exhibit 57: Bio-Rad Laboratories Inc. - Organizational developments
  • Exhibit 58: Bio-Rad Laboratories Inc. - Geographic focus
  • Exhibit 59: Bio-Rad Laboratories Inc. - Segment focus
  • Exhibit 60: Bio-Rad Laboratories Inc. - Key offerings
  • Exhibit 61: Bio-Rad Laboratories Inc. - Key customers
  • Exhibit 62: F. Hoffmann-La Roche Ltd. - Vendor overview
  • Exhibit 63: F. Hoffmann-La Roche Ltd. - Business segments
  • Exhibit 64: F. Hoffmann-La Roche Ltd. - Organizational developments
  • Exhibit 65: F. Hoffmann-La Roche Ltd. - Geographic focus
  • Exhibit 66: F. Hoffmann-La Roche Ltd. - Segment focus
  • Exhibit 67: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibit 68: F. Hoffmann-La Roche Ltd. - Key customers
  • Exhibit 69: Lonza Group Ltd. - Vendor overview
  • Exhibit 70: Lonza Group Ltd. - Business segments
  • Exhibit 71: Lonza Group Ltd. - Organizational developments
  • Exhibit 72: Lonza Group Ltd. - Geographic focus
  • Exhibit 73: Lonza Group Ltd. - Segment focus
  • Exhibit 74: Lonza Group Ltd. - Key offerings
  • Exhibit 75: Lonza Group Ltd. - Key customers
  • Exhibit 76: MaxCyte Inc. - Vendor overview
  • Exhibit 77: MaxCyte Inc. - Business segments
  • Exhibit 78: MaxCyte Inc. - Organizational developments
  • Exhibit 79: MaxCyte Inc. - Key offerings
  • Exhibit 80: MaxCyte Inc. - Key customers
  • Exhibit 81: Merck KGaA - Vendor overview
  • Exhibit 82: Merck KGaA - Business segments
  • Exhibit 83: Merck KGaA - Organizational developments
  • Exhibit 84: Merck KGaA - Geographic focus
  • Exhibit 85: Merck KGaA - Segment focus
  • Exhibit 86: Merck KGaA - Key offerings
  • Exhibit 87: Merck KGaA - Key customers
  • Exhibit 88: Polyplus-transfection SA - Vendor overview
  • Exhibit 89: Polyplus-transfection SA - Product segments
  • Exhibit 90: Polyplus-transfection SA - Organizational developments
  • Exhibit 91: Polyplus-transfection SA - Key offerings
  • Exhibit 92: Polyplus-transfection SA - Key customers
  • Exhibit 93: Promega Corp. - Vendor overview
  • Exhibit 94: Promega Corp. - Product segments
  • Exhibit 95: Promega Corp. - Organizational developments
  • Exhibit 96: Promega Corp. - Key offerings
  • Exhibit 97: Promega Corp. - Key customers
  • Exhibit 98: QIAGEN NV - Vendor overview
  • Exhibit 99: QIAGEN NV - Business segments
  • Exhibit 100: QIAGEN NV - Organizational developments
  • Exhibit 101: QIAGEN NV - Geographic focus
  • Exhibit 102: QIAGEN NV - Segment focus
  • Exhibit 103: QIAGEN NV - Key offerings
  • Exhibit 104: QIAGEN NV - Key customers
  • Exhibit 105: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 106: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 107: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 108: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 109: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 110: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 111: Thermo Fisher Scientific Inc. - Key customers
  • Exhibit 112: Validation techniques employed for market sizing
  • Exhibit 113: Definition of market positioning of vendors